21 Feb Decentralized clinical trial models: Are they here to stay?
Decentralized clinical trials rose in prominence during the COVID-19 pandemic. Are they here to stay?...
News
21 Feb There are at least 500 coronaviruses. We must develop next-gen vaccines now, experts say
Scientists have unveiled a road map for the development of a new vaccine that would be broadly protective against all coronaviruses....
20 Feb DEI in healthcare more important than ever, execs say
The pandemic has revealed the impact of health disparities, so there's an added emphasis for the healthcare industry to focus on diversity, equity, and inclusion (DEI) efforts. ...
19 Feb Rebecca Blank: A life of leadership, scholarship and service
An economist, educator and leader, Chancellor Blank passed away February 17....
17 Feb FDA drug dosage optimization guidelines signal clinical trial reform
The FDA chooses drug optimization as the preferred blueprint for cancer trials. departing from the maximum tolerated dose model....
16 Feb FDA to require diversity plan for clinical trials
The US Food and Drug Administration (FDA) will soon require researchers and companies seeking approval for late-stage clinical trials to submit a plan for ensuring diversity among trial participants....
15 Feb Diversity in clinical trials: Advances and areas for improvement
It is impossible to view a trial as being of high quality without adequate representation of all patient populations....
15 Feb Biden set his ‘moonshot’ on cancer. Meet the doctor trying to get us there
When it comes to curing cancer, President Joe Biden is shifting that sentiment into full throttle. And Dr. Monica Bertagnolli is taking up the challenge....
14 Feb The future of decentralized trials for academic medical centers
In the future, there are benefits to be gained from collaborations between academic medical centers and industry to solve new problems across the spectrum of clinical research....
12 Feb Combatting aggressive breast cancer
Dr. Eva Vivian, a breast cancer survivor, is a strong proponent of preventive medicine, both professionally and for her own health. So when the opportunity arose for Vivian to join a clinical trial testing a vaccine meant to prevent breast cancer development and recurrence, she...